Skip to main content
Top
Published in:

Open Access 01-12-2022 | Subarachnoid Hemorrhage | Research

The risk for future cerebrovascular disease in pregnant women with Moyamoya disease: a nationwide population-based study in South Korea

Authors: Yeonseong Jeong, Yun Ji Jung, Eunjin Noh, Sungyeon Ha, Jeongeun Hwang, Geum Joon Cho, Min-Jeong Oh, Young-Han Kim

Published in: BMC Pregnancy and Childbirth | Issue 1/2022

Login to get access

Abstract

Background

Physiologic changes during pregnancy affect the development of postpartum cerebrovascular disease (CVD) in women with Moyamoya disease. Due to the rare prevalence of Moyamoya disease and its large regional variations, large-scale based studies on the risk of CVD after delivery have not been conducted. This study aimed to evaluate whether women with Moyamoya disease have an increased risk of CVD after delivery.

Methods

Research data was collected from the National Health Insurance Claims Database of the Health Insurance Review and Assessment Service. Patients who delivered in Korea from 2007 to 2014 were enrolled in this study. We classified women as having CVD if they were diagnosed with any of the following conditions between delivery and December 31, 2016; cerebral infarction (I63.X in the International Classification of Diseases-10th Revision [ICD-10]) and/or intracranial hemorrhage (I61.X, I62.X in ICD-10) and/or subarachnoid hemorrhage (I60.X in ICD-10). Women with Moyamoya disease were identified as having I67.5 in ICD-10. We matched the study cohort by the ratio of 1:10 to analyze the risk CVD occurrence. The matching technique applied in this study was based on the variables of age and parity. To evaluate the adjusted hazard ratio (HR) for CVD in women with Moyamoya disease, we used multivariate Cox proportional hazard regression.

Results

Among a total of 3,611,216 Korean women who underwent delivered, we identified 412 women with Moyamoya disease diagnosis and 1420 age- and parity-matched women without Moyamoya disease (control). Compared to the control group, women with Moyamoya disease had a significantly higher rate of Cesarean section, overt DM, and essential hypertension (all p < 0.0001). Among women with Moyamoya disease, 55 (13.35%) women developed CVD within the follow-up postpartum period. The presence of Moyamoya disease was associated with an increased risk of CVD after delivery (adjusted HR 37.42; 95% confidence interval (CI) 17.50-80.02 within 2.3 years) after adjusting for pregnancy-induced hypertension, gestational diabetes mellitus, pregestational diabetes, chronic hypertension.

Conclusion

This population based study showed that the occurrence rate of CVD after delivery was higher in women with Moyamoya disease than in those without. Therefore, careful and long-term postpartum surveillance is required for women with Moyamoya disease.
Literature
1.
go back to reference Ahn IM, Park D-H, Hann HJ, Kim KH, Kim HJ, Ahn HS. Incidence, Prevalence, and Survival of Moyamoya Disease in Korea. Stroke. 2014;45(4):1090–5.CrossRef Ahn IM, Park D-H, Hann HJ, Kim KH, Kim HJ, Ahn HS. Incidence, Prevalence, and Survival of Moyamoya Disease in Korea. Stroke. 2014;45(4):1090–5.CrossRef
2.
go back to reference Church EW, Qaiser R, Bell-Stephens TE, Bigder MG, Chow EK, Han SS, El-Sayed YY, Steinberg GK: Pregnancy after direct cerebral bypass for moyamoya disease. J Neurosurg 2019:1–7. Church EW, Qaiser R, Bell-Stephens TE, Bigder MG, Chow EK, Han SS, El-Sayed YY, Steinberg GK: Pregnancy after direct cerebral bypass for moyamoya disease. J Neurosurg 2019:1–7.
3.
go back to reference Fukushima K, Yumoto Y, Kondo Y, Fujita Y, Morokuma S, Tsukimori K, Wake N. A retrospective chart review of the perinatal period in 22 pregnancies of 16 women with Moyamoya disease. J Clin Neurosci. 2012;19(10):1358–62.CrossRef Fukushima K, Yumoto Y, Kondo Y, Fujita Y, Morokuma S, Tsukimori K, Wake N. A retrospective chart review of the perinatal period in 22 pregnancies of 16 women with Moyamoya disease. J Clin Neurosci. 2012;19(10):1358–62.CrossRef
4.
go back to reference Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease (Review). Exp Ther Med. 2019;17:1977–84.PubMedPubMedCentral Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease (Review). Exp Ther Med. 2019;17:1977–84.PubMedPubMedCentral
5.
go back to reference Williams DL, Martin IL, Gully RM. Intracerebral hemorrhage and Moyamoya disease in pregnancy. Can J Anaesth. 2000;47(10):996–1000.CrossRef Williams DL, Martin IL, Gully RM. Intracerebral hemorrhage and Moyamoya disease in pregnancy. Can J Anaesth. 2000;47(10):996–1000.CrossRef
6.
go back to reference Kim T, Lee H, Bang JS, Kwon OK, Hwang G, Oh CW. Epidemiology of Moyamoya disease in Korea: based on National Health Insurance Service Data. J Korean Neurosurg Soc. 2015;57(6):390.CrossRef Kim T, Lee H, Bang JS, Kwon OK, Hwang G, Oh CW. Epidemiology of Moyamoya disease in Korea: based on National Health Insurance Service Data. J Korean Neurosurg Soc. 2015;57(6):390.CrossRef
7.
go back to reference Jung YJ, Kim M-A, Kwon J-Y, Lee HR, Cho HY, Park YW, Kim YH. Pregnancy outcomes in women with Moyamoya disease: experiences at a single center in Korea. Yonsei Med J. 2015;56(3):793.CrossRef Jung YJ, Kim M-A, Kwon J-Y, Lee HR, Cho HY, Park YW, Kim YH. Pregnancy outcomes in women with Moyamoya disease: experiences at a single center in Korea. Yonsei Med J. 2015;56(3):793.CrossRef
8.
go back to reference Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis). Neurol Med Chir (Tokyo) 2012;52(5):245–66. Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis). Neurol Med Chir (Tokyo) 2012;52(5):245–66.
9.
go back to reference Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T. Prevalence and clinicoepidemiological features of Moyamoya disease in Japan. Stroke. 2008;39(1):42–7.CrossRef Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T. Prevalence and clinicoepidemiological features of Moyamoya disease in Japan. Stroke. 2008;39(1):42–7.CrossRef
10.
go back to reference Inayama Y, Kondoh E, Chigusa Y, Io S, Funaki T, Matsumura N, Miyamoto S, Mandai M. Moyamoya disease in pregnancy: a 20-year single-center experience and literature review. World Neurosurg. 2019;122:684-691.e682.CrossRef Inayama Y, Kondoh E, Chigusa Y, Io S, Funaki T, Matsumura N, Miyamoto S, Mandai M. Moyamoya disease in pregnancy: a 20-year single-center experience and literature review. World Neurosurg. 2019;122:684-691.e682.CrossRef
11.
go back to reference Takahashi JC, Ikeda T, Iihara K, Miyamoto S. Pregnancy and delivery in Moyamoya disease: results of a nationwide survey in Japan. Neurol Med Chir (Tokyo). 2012;52(5):304–10.CrossRef Takahashi JC, Ikeda T, Iihara K, Miyamoto S. Pregnancy and delivery in Moyamoya disease: results of a nationwide survey in Japan. Neurol Med Chir (Tokyo). 2012;52(5):304–10.CrossRef
12.
go back to reference Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension. 2005;46(2):249–54.CrossRef Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension. 2005;46(2):249–54.CrossRef
13.
go back to reference F. Gary Cunningham KJL, Steven L. Bloom, Jodi S. Dashe, Barbara L. Hoffman, Brian M. Casey, Catherine Y. Spong: Williams Obstetrics, 25th; 2018. F. Gary Cunningham KJL, Steven L. Bloom, Jodi S. Dashe, Barbara L. Hoffman, Brian M. Casey, Catherine Y. Spong: Williams Obstetrics, 25th; 2018.
14.
go back to reference Galambosi PJ, Gissler M, Kaaja RJ, Ulander V-M. Incidence and risk factors of venous thromboembolism during postpartum period: a population-based cohort-study. Acta Obstet Gynecol Scand. 2017;96(7):852–61.CrossRef Galambosi PJ, Gissler M, Kaaja RJ, Ulander V-M. Incidence and risk factors of venous thromboembolism during postpartum period: a population-based cohort-study. Acta Obstet Gynecol Scand. 2017;96(7):852–61.CrossRef
15.
go back to reference Kittner SJ, Stern BJ, Feeser BR, Hebel JR, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335(11):768–74.CrossRef Kittner SJ, Stern BJ, Feeser BR, Hebel JR, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335(11):768–74.CrossRef
16.
go back to reference Miyakoshi K, Matsuoka M, Yasutomi D, Tanaka M, Yakubo K, Fukuiya T, Yoshimura Y. Moyamoya-disease-related ischemic stroke in the postpartum period. J Obstet Gynaecol Res. 2009;35(5):974–7.CrossRef Miyakoshi K, Matsuoka M, Yasutomi D, Tanaka M, Yakubo K, Fukuiya T, Yoshimura Y. Moyamoya-disease-related ischemic stroke in the postpartum period. J Obstet Gynaecol Res. 2009;35(5):974–7.CrossRef
17.
go back to reference Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium a study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke. 1995;26(6):930–6.CrossRef Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium a study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke. 1995;26(6):930–6.CrossRef
18.
go back to reference Han K-T, Cho GJ, Kim EH. Evaluation of the association between gestational diabetes mellitus at first pregnancy and cancer within 10 years postpartum using National Health Insurance Data in South Korea. Int J Environ Res Public Health. 2018;15(12):2646.CrossRef Han K-T, Cho GJ, Kim EH. Evaluation of the association between gestational diabetes mellitus at first pregnancy and cancer within 10 years postpartum using National Health Insurance Data in South Korea. Int J Environ Res Public Health. 2018;15(12):2646.CrossRef
19.
go back to reference Kim J-A, Yoon S, Kim L-Y, Kim D-S. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) Data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA Data. J Korean Med Sci. 2017;32(5):718–28.CrossRef Kim J-A, Yoon S, Kim L-Y, Kim D-S. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) Data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA Data. J Korean Med Sci. 2017;32(5):718–28.CrossRef
20.
go back to reference Kim J-Y, Hong JY, Kim D-K. Association of sudden sensorineural hearing loss with risk of cardiocerebrovascular disease. JAMA Otolaryngol Head Neck Surg. 2018;144(2):129.CrossRef Kim J-Y, Hong JY, Kim D-K. Association of sudden sensorineural hearing loss with risk of cardiocerebrovascular disease. JAMA Otolaryngol Head Neck Surg. 2018;144(2):129.CrossRef
21.
go back to reference Lee SU, Kim T, Kwon OK, Bang JS, Ban SP, Byoun HS, Oh CW. Trends in the Incidence and treatment of cerebrovascular diseases in Korea : part i intracranial aneurysm, intracerebral hemorrhage, and arteriovenous malformation. J Korean Neurosurg Soc. 2020;63(1):56–68. Lee SU, Kim T, Kwon OK, Bang JS, Ban SP, Byoun HS, Oh CW. Trends in the Incidence and treatment of cerebrovascular diseases in Korea : part i intracranial aneurysm, intracerebral hemorrhage, and arteriovenous malformation. J Korean Neurosurg Soc. 2020;63(1):56–68.
22.
go back to reference Sj L, Hj K, Cm N, Hs C. Jang YH, Kim S, Kang HY: Socioeconomic Costs of Stroke in Korea: Estimated from the Korea National Health Insurance Claims Database. J Prev Med Public Health. 2009;42(4):251–60.CrossRef Sj L, Hj K, Cm N, Hs C. Jang YH, Kim S, Kang HY: Socioeconomic Costs of Stroke in Korea: Estimated from the Korea National Health Insurance Claims Database. J Prev Med Public Health. 2009;42(4):251–60.CrossRef
23.
go back to reference Therneau TM, Grambsch P. Modeling Survival Data: Extending the Cox Model (Statistics for Biology and Health): Springer; 2000. Therneau TM, Grambsch P. Modeling Survival Data: Extending the Cox Model (Statistics for Biology and Health): Springer; 2000.
24.
go back to reference Therneau TM. A Package for Survival Analysis in R. In.; 2021. Therneau TM. A Package for Survival Analysis in R. In.; 2021.
25.
go back to reference Kassambara A, Kosinski M, Biecek P, Fabian A. Survminer: Drawing Survival Curves using 'ggplot2'. 2021. Kassambara A, Kosinski M, Biecek P, Fabian A. Survminer: Drawing Survival Curves using 'ggplot2'. 2021.
26.
go back to reference Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL, Sacco RL, Berman MF. Intracerebral hemorrhage in pregnancy: Frequency, risk factors, and outcome. Neurology. 2006;67(3):424–9.CrossRef Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL, Sacco RL, Berman MF. Intracerebral hemorrhage in pregnancy: Frequency, risk factors, and outcome. Neurology. 2006;67(3):424–9.CrossRef
27.
go back to reference Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37.CrossRef Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37.CrossRef
28.
go back to reference Kim T-S, Lee J-H, Kim I-Y, Lee J-K, Jung S, Kim J-H, Kim S-H, Kang S-S. Moyamoya disease with repeated intracranial haemorrhage in two consecutive pregnancies. J Clin Neurosci. 2004;11(5):525–7.CrossRef Kim T-S, Lee J-H, Kim I-Y, Lee J-K, Jung S, Kim J-H, Kim S-H, Kang S-S. Moyamoya disease with repeated intracranial haemorrhage in two consecutive pregnancies. J Clin Neurosci. 2004;11(5):525–7.CrossRef
29.
go back to reference Komiyama M, Yasui T, Kitano S, Sakamoto H, Fujitani K, Matsuo S. Moyamoya disease and pregnancy: case report and review of the literature. Neurosurgery. 1998;43(2):360–8.CrossRef Komiyama M, Yasui T, Kitano S, Sakamoto H, Fujitani K, Matsuo S. Moyamoya disease and pregnancy: case report and review of the literature. Neurosurgery. 1998;43(2):360–8.CrossRef
30.
go back to reference Fujimura M, Akagi K, Uenohara H, Tominaga T. Moyamoya disease in pregnancy: a single institute experience. Neurol Med Chir (Tokyo). 2013;53(8):561–4.CrossRef Fujimura M, Akagi K, Uenohara H, Tominaga T. Moyamoya disease in pregnancy: a single institute experience. Neurol Med Chir (Tokyo). 2013;53(8):561–4.CrossRef
31.
go back to reference Ikeda T, Neki R, Suga S, Takahashi J, Iihara K, Miyamoto S. Intrapartum epidural analgesia for patients with moyamoya disease. Japanese Journal of Neurosurgery. 2009;18(5):376–82.CrossRef Ikeda T, Neki R, Suga S, Takahashi J, Iihara K, Miyamoto S. Intrapartum epidural analgesia for patients with moyamoya disease. Japanese Journal of Neurosurgery. 2009;18(5):376–82.CrossRef
32.
go back to reference Tanaka H, Katsuragi S, Tanaka K, Miyoshi T, Kamiya C, Iwanaga N, Neki R, Takahashi JC, Ikeda T, Yoshimatsu J. Vaginal delivery in pregnancy with Moyamoya disease: Experience at a single institute. J Obstet Gynaecol Res. 2015;41(4):517–22.CrossRef Tanaka H, Katsuragi S, Tanaka K, Miyoshi T, Kamiya C, Iwanaga N, Neki R, Takahashi JC, Ikeda T, Yoshimatsu J. Vaginal delivery in pregnancy with Moyamoya disease: Experience at a single institute. J Obstet Gynaecol Res. 2015;41(4):517–22.CrossRef
33.
go back to reference Sato K, Yamada M, Okutomi T, Kato R, Unno N, Fujii K, Kumabe T. Vaginal delivery under epidural analgesia in pregnant women with a diagnosis of Moyamoya disease. J Stroke Cerebrovasc Dis. 2015;24(5):921–4.CrossRef Sato K, Yamada M, Okutomi T, Kato R, Unno N, Fujii K, Kumabe T. Vaginal delivery under epidural analgesia in pregnant women with a diagnosis of Moyamoya disease. J Stroke Cerebrovasc Dis. 2015;24(5):921–4.CrossRef
34.
go back to reference Sei K, Sasa H, Furuya K. Moyamoya disease and pregnancy: case reports and criteria for successful vaginal delivery. Clinical Case Reports. 2015;3(4):251–4.CrossRef Sei K, Sasa H, Furuya K. Moyamoya disease and pregnancy: case reports and criteria for successful vaginal delivery. Clinical Case Reports. 2015;3(4):251–4.CrossRef
Metadata
Title
The risk for future cerebrovascular disease in pregnant women with Moyamoya disease: a nationwide population-based study in South Korea
Authors
Yeonseong Jeong
Yun Ji Jung
Eunjin Noh
Sungyeon Ha
Jeongeun Hwang
Geum Joon Cho
Min-Jeong Oh
Young-Han Kim
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2022
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-022-04718-8

Other articles of this Issue 1/2022

BMC Pregnancy and Childbirth 1/2022 Go to the issue